Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis

CD34 Selected Cells for the Treatment of Poor Graft Function after Allogeneic Stem Cell Transplantation

(2014) Alessandra Stasia et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Dynamic of Bone Marrow Fibrosis Regression Predicts Survival after Allogeneic Stem Cell Transplantation for Myelofibrosis

(2014) Nicolaus Kröger et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Association of an Impaired Bone Marrow Microenvironment with Secondary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

(2013) Yuan Kong et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

CD34+-Selected Stem Cell Boost without Further Conditioning for Poor Graft Function after Allogeneic Stem Cell Transplantation in Patients with Hematological Malignancies

(2013) Evgeny Klyuchnikov et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis

(2010) H. Alchalby et al.   BLOOD

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

(2009) N. Kroger et al.   BLOOD

Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type

(2009) A Bacigalupo et al.   BONE MARROW TRANSPLANTATION

A reduced intensity conditioning protocol associated with excellent survival in patients with myelofibrosis

(2008) B George et al.   BONE MARROW TRANSPLANTATION

Graft Failure after Allogeneic Hematopoietic Cell Transplantation

(2007) Jonas Mattsson et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION